deltatrials
Active Not Recruiting NA INTERVENTIONAL 8-arm NCT03877276

Dietary Oxalate and Immune Cell Function

Sponsor: University of Alabama at Birmingham

Conditions Kidney Stone
Updated 11 times since 2019 Last updated: Jun 5, 2025 Started: Jul 21, 2016 Primary completion: Jun 1, 2026 Completion: Dec 1, 2027
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Kidney Stone, this trial is ongoing. The trial is conducted by University of Alabama at Birmingham and has accumulated 11 data snapshots since 2016. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Study Description(click to expand)

Inflammation and dietary oxalate have been shown to play an important role in the development of kidney stones. Oxalate is a small molecule found in plants and plant-derived food. Individuals that have high oxalate intake have an increased risk of developing kidney stones. The co-investigators have previously shown that healthy subjects that consume dietary oxalate have increased plasma and urine oxalate. White blood cells are essential for the immune response and rely on the mitochondria to carry out important cell functions. The Principal Investigator's current research shows that patients with calcium oxalate kidney stones have decreased mitochondrial function in their immune cells. Using the expertise of the investigators, this study will test whether oxalate has a direct effect on mitochondrial function in immune cells from healthy subjects. This information could help us understand the role of oxalate on the immune system during kidney stone pathogenesis.

Inflammation and dietary oxalate have been shown to play an important role in the development of kidney stones. Oxalate is a small molecule found in plants and plant-derived food. Individuals that have high oxalate intake have an increased risk of developing kidney stones. The co-investigators have previously shown that healthy subjects that consume dietary oxalate have increased plasma and urine oxalate.

White blood cells are essential for the immune response and rely on the mitochondria to carry out important cell functions. The Principal Investigator's current research shows that patients with calcium oxalate kidney stones have decreased mitochondrial function in their immune cells. Using the expertise of the investigators, this study will test whether oxalate has a direct effect on mitochondrial function in immune cells from healthy subjects. This information could help us understand the role of oxalate on the immune system during kidney stone pathogenesis.

Status Flow

~Apr 2019 – ~Apr 2020 · 12 months · monthly snapshotRecruiting~Apr 2020 – ~Jan 2021 · 9 months · monthly snapshotRecruiting~Jan 2021 – ~Nov 2021 · 10 months · monthly snapshotRecruiting~Nov 2021 – ~Sep 2022 · 10 months · monthly snapshotRecruiting~Sep 2022 – ~May 2023 · 8 months · monthly snapshotRecruiting~May 2023 – ~Sep 2023 · 4 months · monthly snapshotActive Not Recruiting~Sep 2023 – ~Jan 2024 · 4 months · monthly snapshotActive Not Recruiting~Jan 2024 – ~Jul 2024 · 6 months · monthly snapshotActive Not Recruiting~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotActive Not Recruiting~Sep 2024 – ~Jul 2025 · 10 months · monthly snapshotActive Not Recruiting~Jul 2025 – present · 9 months · monthly snapshotActive Not Recruiting

Change History

11 versions recorded
  1. Jul 2025 — Present [monthly]

    Active Not Recruiting NA

  2. Sep 2024 — Jul 2025 [monthly]

    Active Not Recruiting NA

  3. Jul 2024 — Sep 2024 [monthly]

    Active Not Recruiting NA

  4. Jan 2024 — Jul 2024 [monthly]

    Active Not Recruiting NA

  5. Sep 2023 — Jan 2024 [monthly]

    Active Not Recruiting NA

Show 6 earlier versions
  1. May 2023 — Sep 2023 [monthly]

    Active Not Recruiting NA

    Status: RecruitingActive Not Recruiting

  2. Sep 2022 — May 2023 [monthly]

    Recruiting NA

  3. Nov 2021 — Sep 2022 [monthly]

    Recruiting NA

  4. Jan 2021 — Nov 2021 [monthly]

    Recruiting NA

  5. Apr 2020 — Jan 2021 [monthly]

    Recruiting NA

  6. Apr 2019 — Apr 2020 [monthly]

    Recruiting NA

    First recorded

Jul 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • University of Alabama at Birmingham
Data source: University of Alabama at Birmingham

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations